Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
Clinical trial NCT05887908 · COMPLETED
Trial details
- NCT number
- NCT05887908
- Sponsor
- Meiji Seika Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2024-11-22
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.